Elisabeth André‐Garnier

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

Pierre Frange, Lambert Assoumou, Diane Descamps et al. · Journal of Antimicrobial Chemotherapy · 2015 · 44 citations · Full text

Phi Patients, Immunodeficiencies, First-line Strategies +17

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

Charlotte Charpentier, Isabelle Malet, Elisabeth André‐Garnier et al. · Journal of Antimicrobial Chemotherapy · 2017 · 44 citations · Full text

Genotyping and resistance profile of hepatitis C (HCV) genotypes 1–6 by sequencing the NS3 protease region using a single optimized sensitive method

Bernard Besse, Marianne Coste‐Burel, Nathalie Bourgeois et al. · Journal of Virological Methods · 2012 · 30 citations

Hepatology, Hepatitis C, Viral Hepatitis +12

Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre‐emptive therapy

Céline Bressollette‐Bodin, Marianne Coste‐Burel, Bernard Besse et al. · Journal of Medical Virology · 2008 · 29 citations · Full text

Viral Diagnostics, Immunology, Blood Cell +17

Nevirapine–Raltegravir Combination, An Nrti and Pi/R Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients

Véronique Reliquet, Catherine Chirouze, Clotilde Allavena et al. · Antiviral Therapy · 2013 · 27 citations · Full text